EOFBY: AI 评分 40/100 — AI 分析 (4月 2026)

Ecofibre Limited is an Australian-based company focused on breeding, growing, manufacturing, and selling hemp products. The company operates through segments like Ananda Health, Ananda Food, and Hemp Black, offering a range of CBD, food, and textile products.

Key Facts: AI Score: 40/100 Sector: Healthcare

公司概况

概要：

Ecofibre Limited is an Australian hemp company operating in the healthcare sector, focusing on CBD products, hemp-based foods, and textiles. With a negative profit margin and trading as an ADR on the OTC market, Ecofibre faces challenges in a competitive landscape against companies like BIOGF and CKMTF.

EOFBY是做什么的？

Ecofibre Limited, established in 2009 and headquartered in Sydney, Australia, is a vertically integrated hemp company. It cultivates, manufactures, and markets a diverse range of hemp-derived products across the United States and Australia. The company operates through three primary segments: Ananda Health, Ananda Food, and Hemp Black. Ananda Health focuses on CBD products for human and pet consumption, including oils, capsules, and topical creams. Ananda Food offers hemp-related food products such as hemp seeds, protein powders, and snacks. Hemp Black develops and markets textile and hemp-based industrial products. Ecofibre's business model encompasses the entire hemp value chain, from seed to sale, allowing for quality control and product innovation. The company aims to capitalize on the growing demand for hemp-derived products in the health, wellness, and industrial sectors. However, it faces competition from established players in the CBD and hemp industries, requiring continuous innovation and effective marketing strategies to maintain and grow its market share. Ecofibre's products are available through various channels, including online retail, brick-and-mortar stores, and partnerships with healthcare professionals.

EOFBY的投资论点是什么？

Investing in Ecofibre Limited (EOFBY) presents a speculative opportunity due to its presence in the emerging hemp and CBD market. However, the company's negative profit margin of -158.5% and negative gross margin of -3.9% raise concerns about its financial sustainability. The company's beta of 1.54 suggests higher volatility compared to the market. Growth catalysts include expansion of its product lines and increased market penetration in the US and Australia. The investment thesis hinges on Ecofibre's ability to achieve profitability and effectively compete in a crowded market. Investors should carefully consider the risks associated with investing in an OTC-traded ADR with limited financial disclosure.

EOFBY在哪个行业运营？

Ecofibre Limited operates within the rapidly evolving hemp and CBD industry. The market is characterized by increasing consumer demand for hemp-derived products, driven by perceived health and wellness benefits. However, the industry is also subject to regulatory uncertainty and intense competition. Key players include established CBD brands, pharmaceutical companies, and agricultural businesses. Ecofibre's success depends on its ability to differentiate its products, navigate regulatory hurdles, and establish strong distribution channels. The industry is expected to continue growing, but profitability remains a challenge for many companies due to high operating costs and marketing expenses.

Drug Manufacturers - Specialty & Generic

Healthcare

EOFBY有哪些增长机遇？

Expansion of Ananda Health Product Line: Ecofibre has the opportunity to expand its Ananda Health segment by introducing new CBD-based products targeting specific health conditions. The global CBD market is projected to reach $55.79 billion by 2028, growing at a CAGR of 25.9% from 2021. This expansion could include developing formulations for sleep, anxiety, and pain management, leveraging the growing consumer interest in natural health solutions. Success hinges on rigorous testing, regulatory compliance, and effective marketing.
Increased Market Penetration in the United States: Ecofibre can increase its market share in the United States by expanding its distribution network and marketing efforts. The US is the largest CBD market globally, with significant growth potential. This could involve partnerships with major retailers, online marketplaces, and healthcare providers. Effective branding and consumer education are crucial for success in this competitive market. The timeline for significant market penetration is estimated at 2-3 years.
Development of Hemp-Based Industrial Products: Ecofibre has the potential to capitalize on the growing demand for sustainable and eco-friendly materials by developing hemp-based industrial products. This includes textiles, building materials, and bioplastics. The global market for industrial hemp is projected to reach $15.2 billion by 2027. Ecofibre can leverage its expertise in hemp cultivation and processing to create innovative and competitive products. Research and development, strategic partnerships, and government support are essential for success.
Expansion of Ananda Food Segment: Ecofibre can expand its Ananda Food segment by introducing new hemp-based food products and increasing its distribution channels. The global hemp food market is experiencing significant growth, driven by increasing consumer awareness of the nutritional benefits of hemp seeds and protein. This expansion could include developing hemp-based snacks, beverages, and ingredients for food manufacturers. Effective marketing and product innovation are crucial for success.
Strategic Partnerships and Acquisitions: Ecofibre can pursue strategic partnerships and acquisitions to expand its product portfolio, market reach, and technological capabilities. This could involve partnering with other hemp companies, pharmaceutical companies, or technology providers. Acquisitions can provide access to new markets, technologies, and intellectual property. Careful due diligence and integration are essential for successful partnerships and acquisitions.

Market capitalization of $0.07 billion indicates a small-cap company.
Negative P/E ratio of -0.16 reflects current losses and lack of profitability.
Profit margin of -158.5% signals significant operational inefficiencies or high costs.
Gross margin of -3.9% suggests challenges in managing the cost of goods sold.
Beta of 1.54 indicates higher volatility compared to the overall market.

EOFBY提供哪些产品和服务？

Breeds and grows hemp plants.
Manufactures CBD products for human consumption.
Manufactures CBD products for pet consumption.
Produces topical health and beauty products.
Creates hemp-related food products.
Develops textile and hemp products.

EOFBY如何赚钱？

Vertically integrated hemp production from seed to sale.
Manufacturing and distribution of CBD products.
Sales of hemp-based food and textile products.

Individuals seeking CBD products for health and wellness.
Pet owners looking for CBD products for their pets.
Consumers interested in hemp-based food products.
Businesses seeking hemp-based textiles and industrial materials.

Vertically integrated operations providing control over the supply chain.
Proprietary hemp genetics and cultivation techniques.
Established brand recognition in the Australian market.
Expertise in hemp processing and product development.

什么因素可能推动EOFBY股价上涨？

Upcoming: Potential regulatory changes in the US regarding CBD products could open new market opportunities.
Ongoing: Increasing consumer awareness and acceptance of CBD and hemp-based products.
Ongoing: Expansion of distribution channels and partnerships with major retailers.

EOFBY的主要风险是什么？

Potential: Regulatory uncertainty and evolving legal landscape for hemp and CBD products.
Ongoing: Intense competition in the hemp and CBD market.
Ongoing: Negative profit and gross margins raise concerns about financial sustainability.
Potential: Fluctuations in hemp prices and agricultural risks.

EOFBY的核心优势是什么？

Vertically integrated operations.
Proprietary hemp genetics.
Established brand in Australia.
Diverse product portfolio.

EOFBY的劣势是什么？

Negative profit margin.
Limited market presence in the United States.
Reliance on the hemp and CBD market.
OTC listing indicates higher risk.

EOFBY有哪些机遇？

Expansion into new markets.
Development of new hemp-based products.
Strategic partnerships and acquisitions.
Increasing consumer demand for CBD products.

EOFBY面临哪些威胁？

Regulatory uncertainty in the hemp and CBD market.
Intense competition.
Fluctuations in hemp prices.
Potential changes in consumer preferences.

EOFBY的竞争对手是谁？

BioHarvest Sciences Inc. — Focuses on biotechnology and plant cell growth. — (BIOGF)
MediPharm Labs Corp. — Specializes in cannabis extraction and purification. — (CKMTF)
Emerald Health Therapeutics Inc. — Develops cannabis and hemp products. — (EEOIF)
Entourage Health Corp. — Cultivates and distributes cannabis products. — (ETXPF)
Cronos Group Inc. — Global cannabis company with diverse brands. — (GDNSF)

Key Metrics

MoonshotScore: 40/100

Company Profile

CEO: Eric Wang
Headquarters: Sydney, AU
Founded: 2022

AI Insight

AI analysis pending for EOFBY

ADR Level: 1
ADR Ratio: 1:1
Home Market Ticker: EOFB

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does Ecofibre Limited do?

Ecofibre Limited is a vertically integrated hemp company that cultivates, manufactures, and markets a range of hemp-derived products. These products include CBD oils, capsules, and topical creams under the Ananda Health brand; hemp-based food products under the Ananda Food brand; and textile and industrial products under the Hemp Black brand. The company operates in both the United States and Australia, targeting consumers seeking natural health and wellness solutions, as well as businesses seeking sustainable materials.

What do analysts say about EOFBY stock?

As of 2026-03-18, formal analyst ratings and price targets for EOFBY are unavailable, likely due to its OTC listing and smaller market capitalization. Investors should conduct their own thorough due diligence and consider the company's financial performance, growth prospects, and risk factors before making any investment decisions. Key metrics to monitor include revenue growth, profitability, and cash flow.

What are the main risks for EOFBY?

The main risks for Ecofibre Limited include regulatory uncertainty in the hemp and CBD market, intense competition from established players, and the company's current negative profit and gross margins. Additionally, fluctuations in hemp prices and agricultural risks could impact the company's profitability. As an OTC-traded ADR, EOFBY is also subject to liquidity risk and potential price volatility. Investors should carefully consider these risks before investing.